Filing Details
- Accession Number:
- 0001209191-22-042002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-13 10:13:23
- Reporting Period:
- 2022-07-12
- Accepted Time:
- 2022-07-13 10:13:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1651311 | Merus N.v. | MRUS | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1682126 | Ante Sven Lundberg | C/O Merus N.v. Yalelaan 62 Utrecht P7 3584 CM | President, Ceo & Pfo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2022-07-12 | 4,340 | $22.97 | 19,340 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Sold in pursuant to 10B5-1 plan dated 6/10/22
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.75 to $23.00, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
Billionaire Hedge Funds
